Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Minerva Neuroscie (NQ: NERV ) 2.410 -0.020 (-0.82%) Streaming Delayed Price Updated: 12:37 PM EDT, Oct 31, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Minerva Neuroscie < Previous 1 2 3 4 5 6 Next > NERV Stock Earnings: Minerva Neurosciences Misses EPS for Q2 2024 August 06, 2024 NERV stock results show that Minerva Neurosciences missed analyst estimates for earnings per share the second quarter of 2024. Via InvestorPlace Minerva Neurosciences Reports Second Quarter 2024 Financial Results and Business Updates August 06, 2024 From Minerva Neurosciences, Inc Via GlobeNewswire NERV Stock Earnings: Minerva Neurosciences Beats EPS for Q1 2024 May 01, 2024 NERV stock results show that Minerva Neurosciences beat analyst estimates for earnings per share the first quarter of 2024. Via InvestorPlace Minerva Neurosciences Reports First Quarter 2024 Financial Results and Business Updates May 01, 2024 From Minerva Neurosciences, Inc Via GlobeNewswire Minerva Neurosciences: Q4 Earnings Insights February 22, 2024 Via Benzinga Minerva Neurosciences Inc. (NASDAQ: NERV) Near the Top of Equities by Percentage Gain on 6/28 June 28, 2023 Via Investor Brand Network Dow Dips Over 100 Points; J.M. Smucker Posts Upbeat Earnings February 27, 2024 U.S. stocks traded mixed toward the end of trading, with the Dow Jones index falling more than 100 points on Tuesday. The Dow traded down 0.35% to 38,932.26 while the NASDAQ rose 0.28% to 16,021.41.... Via Benzinga Topics Stocks Exposures US Equities Why Helix Energy Solutions Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session February 27, 2024 Shares of Helix Energy Solutions Group, Inc. (NYSE: HLX) fell sharply during Tuesday’s session following weak earnings. Via Benzinga Regulatory Setback For Minerva Neurosciences' Schizophrenia Treatment Candidate, FDA Asks For More Data February 27, 2024 Minerva Neurosciences faces FDA challenges for roluperidone in schizophrenia treatment. Understand the clinical deficiencies and potential paths forward. Cash position at December 31, 2023, around... Via Benzinga Exposures Product Safety 12 Health Care Stocks Moving In Tuesday's Intraday Session February 27, 2024 Via Benzinga Crude Oil Gains 1%; Macy's Plans To Close 150 Stores February 27, 2024 U.S. stocks traded mixed midway through trading, with the Dow Jones index falling around 150 points on Tuesday. The Dow traded down 0.39% to 38,915.65 while the NASDAQ rose 0.15% to 15,999.50. The S&P... Via Benzinga Topics Stocks Exposures Fossil Fuels US Equities Nasdaq Rises 50 Points; Lowe's Earnings Top Views February 27, 2024 U.S. stocks traded mixed this morning, with the Nasdaq Composite gaining around 50 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.07% to 39,043.13 while the NASDAQ rose... Via Benzinga Topics Stocks Exposures US Equities Minerva Neurosciences Receives Complete Response Letter from FDA for New Drug Application for Roluperidone for the Treatment of Negative Symptoms in Patients with Schizophrenia February 27, 2024 From Minerva Neurosciences, Inc Via GlobeNewswire Minerva Neurosciences Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Business Updates February 22, 2024 From Minerva Neurosciences, Inc Via GlobeNewswire 12 Health Care Stocks Moving In Thursday's Intraday Session February 08, 2024 Via Benzinga 12 Health Care Stocks Moving In Monday's After-Market Session February 05, 2024 Via Benzinga Minerva Neurosciences Reports 2023 Third Quarter Financial Results and Business Updates November 07, 2023 From Minerva Neurosciences, Inc Via GlobeNewswire Minerva Neurosciences Reports 2023 Second Quarter Financial Results and Business Updates August 01, 2023 From Minerva Neurosciences, Inc Via GlobeNewswire 10 Short Squeeze Stocks To Watch: Baosheng Media, Toro Corp, Getty Images And More July 18, 2023 Potential short squeeze plays gained steam in 2021, continued throughout 2022, and remain a focus of new traders looking for the next huge move. High short interest and steep borrowing costs are among... Via Benzinga Top 5 Health Care Stocks That May Collapse This Quarter July 10, 2023 The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies. Via Benzinga Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Are Secretly Monitoring But Not Talking About Yet June 30, 2023 Investors are on the hunt for undervalued, underfollowed and emerging stocks, and retail traders have countless methods at their disposal to uncover new information. For some, this may be... Via Benzinga BioXcel Therapeutics, Alvotech And Other Big Stocks Moving Lower On Thursday June 29, 2023 U.S. stocks traded higher, with the Dow Jones gaining around 200 points on Thursday. Here are some big stocks recording losses in today’s session. Via Benzinga Why Franklin Covey Shares Are Trading Higher By 25%? Here Are Other Stocks Moving In Thursday's Mid-Day Session June 29, 2023 Gainers Sigilon Therapeutics, Inc. (NASDAQ: SGTX) shares climbed 523.8% to $24.25 after Eli Lilly agreed to acquire the company for $14.92/share in cash. Via Benzinga 12 Health Care Stocks Moving In Thursday's Pre-Market Session June 29, 2023 Via Benzinga Why CorMedix Are Trading Lower By 22%; Here Are 20 Stocks Moving Premarket June 29, 2023 Gainers Eco Wave Power Global AB (NASDAQ: WAVE) shares surged 123% to $3.48 in pre-market trading after dropping over 8% on Wednesday. Via Benzinga Crude Oil Rises Sharply; Unifirst Earnings Miss Expectations June 28, 2023 U.S. stocks traded mixed toward the end of trading, with the Dow Jones dropping around 100 points on Wednesday. The Dow traded down 0.32% to 33,818.48 while the NASDAQ rose 0.23% to 13,586.93. The S&P... Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session June 28, 2023 Via Benzinga Why Eton Pharmaceuticals Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session June 28, 2023 Gainers Minerva Neurosciences, Inc. (NASDAQ: NERV) surged 46.2% to $8.80. Minerva Neurosciences announced $20 million in private placement priced at a premium to market. Via Benzinga Nasdaq Moves Higher; US Crude Stocks Drop More than Projected June 28, 2023 U.S. stocks traded mixed midway through trading, with the Nasdaq Composite gaining over 80 points on Wednesday. The Dow traded down 0.42% to 33,784.59 while the NASDAQ rose 0.63% to 13,640.83. The S&P... Via Benzinga Why Minerva Neurosciences Stock Is Shooting Higher Today June 28, 2023 Minerva Neurosciences, Inc (NASDAQ: NERV) are shooting higher after the company bagged a $20 million investment from Boehringer Ingelheim and Federated Hermes Kaufmann Funds via Via Benzinga < Previous 1 2 3 4 5 6 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
